| Outcome Measures: |
Primary: Change in HbA1c From Baseline to Week 26., Change in HbA1c from baseline to Week 26., Baseline, Week 26 | Secondary: Percentage of Patients Achieving HbA1c Targets <=7% at Week 26, Percentage of patients achieving HbA1c \<=7% at Week 26 (for patients with HbA1c \>7% at baseline)., Baseline, Week 26|Percentage of Patients Achieving HbA1c Targets <=6.5% at Week 26, Percentage of patients achieving HbA1c \<=6.5% at Week 26 (for patients with HbA1c \>6.5% at baseline)., Baseline, Week 26|Change in Fasting Serum Glucose (FSG) From Baseline to Week 26, Change in FSG from baseline to Week 26., Baseline, Week 26|Change in Body Weight (BW) From Baseline to Week 26, Change in BW from baseline to Week 26., Baseline, Week 26|Change in Total Cholesterol (TC) From Baseline to Week 26, Change in TC from baseline to Week 26., Baseline, Week 26|Change in High-Density Lipoprotein (HDL) From Baseline to Week 26, Change in HDL from baseline to Week 26., Baseline, Week 26|Ratio of Triglycerides (TG) at Week 26 to Baseline, Ratio of TG (measured in mg/dL) at Week 26 to baseline. Log(Post-baseline TG) - log(Baseline TG); change from baseline to Week 26 is presented as ratio of Week 26 to baseline., Baseline, Week 26|Change in Blood Pressure From Baseline to Week 26, Change in systolic blood pressure and diastolic blood pressure from baseline to Week 26., Baseline, Week 26|Assessment of Event Rate of Treatment-emergent Hypoglycemic Events, Major hypoglycemia: any episode with symptoms consistent with hypoglycemia that resulted in loss of consciousness or seizure with prompt recovery in response to administration of glucagon or glucose OR documented hypoglycemia (blood glucose \<3.0 mmol/L \[54 mg/dL\]) and required the assistance of another person. Minor hypoglycemia: any sign or symptom associated with hypoglycemia that is either self-treated by the patient or resolves on its own AND has a concurrent finger stick blood glucose \<3.0 mmol/L (54 mg/dL) and not classified as major hypoglycemia. Event rate per subject year was calculated for each subject: (number of events observed from a subject/exposure from a subject)\*365.25 where exposure = last post-baseline visit date - baseline visit date. Mean and Standard Error were then derived from ITT., Baseline to Week 26
|
| Locations: |
Research Site, Beijing, China|Research Site, Chengdu, China|Research Site, Chongqin, China|Research Site, Guangzhou, China|Research Site, Shanghai, China|Research Site, Ahmedabad, India|Research Site, Aligarh, India|Research Site, Bangalore, India|Research Site, Ghaziabad, India|Research Site, Hyderabaad, India|Research Site, Indore, India|Research Site, Kolkata, India|Research Site, Mumbai, India|Research Site, Pune, India|Research Site, Trivandrum, India|Research Site, Uttar Pradesh, India|Research Site, Varanasi, India|Research Site, Ageo, Japan|Research Site, Chiyoda-ku, Japan|Research Site, Izumisano, Japan|Research Site, Kashiwara, Japan|Research Site, Kitaazumi-gun, Japan|Research Site, Kumamoto, Japan|Research Site, Kurume, Japan|Research Site, Matsumoto, Japan|Research Site, Matsuyama, Japan|Research Site, Miyazaki-shi, Japan|Research Site, Ooita-shi, Japan|Research Site, Osaka, Japan|Research Site, Ota-ku, Japan|Research Site, Shinjuku-ku, Japan|Research Site, Takatsuki, Japan|Research Site, Yokohama, Japan|Research Site, Bucheon, Korea, Republic of|Research Site, Daegu, Korea, Republic of|Research Site, Seoul, Korea, Republic of|Research Site, Changhua, Taiwan|Research Site, Chia-Yi, Taiwan|Research Site, Kaohsiung, Taiwan|Research Site, Tainan, Taiwan|Research Site, Taipei, Taiwan|Research Site, Taoyuan, Taiwan
|